…
GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as membership programs, standby and special events, national ambulance contract with the federal emergency management agency, and other state agency and health system contracts to coordinate EMS responses. It serves health systems, large regional systems, and smaller independent hospitals, local communities, health systems, payors, public health and local, state, and federal agencies. The company was incorporated in 2015 and is headquartered in Lewisville, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information and regulatory filings for GMR Solutions Inc. (NYSE: GMRS) are limited, making its precise operations and revenue drivers difficult to verify. The company may benefit from execution of any niche market strategy and operational scalability if management articulates a clear growth plan, which could support long-term revenue expansion and investor interest.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Income before tax | 316.53M | 114.52M | -160.59M |
| Net income | 206.23M | 20.41M | -202.66M |
| Selling general administrative | 191.57M | 3224.17M | 2997.45M |
| Gross profit | 2232.70M | 2438.72M | 2078.61M |
| Reconciled depreciation | 329.59M | 297.80M | 314.45M |
| Ebit | 739.19M | - | - |
| Ebitda | 1068.79M | - | - |
| Depreciation and amortization | 329.59M | - | - |
| Operating income | 824.12M | 721.52M | 421.11M |
| Other operating expenses | 4915.66M | - | - |
| Interest expense | 422.67M | 499.25M | 521.16M |
| Tax provision | 110.30M | 94.11M | 42.07M |
| Net interest income | -422.67M | -499.25M | -521.16M |
| Income tax expense | 110.30M | - | - |
| Total revenue | 5739.78M | 5976.20M | 5394.71M |
| Total operating expenses | 1408.59M | 5254.68M | 4973.60M |
| Cost of revenue | 3507.07M | 3537.48M | 3316.10M |
| Total other income expense net | -507.59M | -107.75M | -60.53M |
| Net income from continuing ops | 206.23M | 20.41M | -202.66M |
| Breakdown | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Type | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 |
| Total assets | 7482.05M | 7116.60M |
| Intangible assets | 1204.24M | 1308.52M |
| Other current assets | 233.59M | 124.20M |
| Total liab | 7277.89M | 6928.60M |
| Total stockholder equity | 204.16M | 188.00M |
| Other current liab | 726.11M | - |
| Common stock | 0.00M | - |
| Capital stock | 0.00M | 0.00M |
| Retained earnings | -259.49M | -465.72M |
| Good will | 2180.58M | 2180.58M |
| Cash | 609.35M | 352.29M |
| Total current liabilities | 1064.43M | 1015.43M |
| Current deferred revenue | 52.14M | - |
| Net debt | 4762.10M | 4192.95M |
| Short term debt | 225.86M | - |
| Short long term debt | 147.14M | 162.22M |
| Short long term debt total | 5371.45M | - |
| Other stockholder equity | 456.47M | - |
| Total current assets | 2132.08M | 1817.54M |
| Short term investments | 78.61M | 82.51M |
| Net receivables | 1094.81M | 1077.82M |
| Long term debt | 4898.77M | 4383.02M |
| Inventory | 115.72M | 105.70M |
| Accounts payable | 60.05M | 54.66M |
| Accumulated other comprehensive income | 7.18M | - |
| Non currrent assets other | 315.58M | 286.75M |
| Non current assets total | 5349.96M | 5299.06M |
| Capital lease obligations | 325.54M | 315.11M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Investments | 2.63M | 93.11M | 4.26M |
| Total cashflows from investing activities | -249.97M | - | - |
| Net borrowings | 397.16M | -987.27M | -142.18M |
| Total cash from financing activities | -135.84M | -59.24M | -142.18M |
| Net income | 206.23M | 20.41M | -202.66M |
| Change in cash | 255.33M | 234.45M | -27.50M |
| Begin period cash flow | 368.90M | 134.45M | 161.96M |
| End period cash flow | 624.23M | 368.90M | 134.45M |
| Total cash from operating activities | 641.15M | 246.21M | 257.75M |
| Depreciation | 329.59M | 297.80M | 314.45M |
| Other cashflows from investing activities | 3.12M | - | - |
| Change to account receivables | -16.99M | -96.86M | 41.83M |
| Sale purchase of stock | -0.09M | -1.01M | 0.00M |
| Other cashflows from financing activities | -532.92M | - | - |
| Capital expenditures | 258.54M | 268.62M | 171.01M |
| Change in working capital | -14.99M | -168.96M | 53.20M |
| Stock based compensation | 2.27M | 14.55M | 6.16M |
| Other non cash items | 78.76M | 76.89M | 32.41M |
| Free cash flow | 382.60M | -22.41M | 86.74M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| GMRS GMR Solutions Inc. |
-0.54 4.59% |
11.22 | - | - | 0.12 | 0.91 | 0.86 | 5.35 |
| HCA HCA Healthcare, Inc. |
1.62 0.32% |
506.04 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-1.82 0.62% |
291.15 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
-0.30 2.00% |
14.69 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as membership programs, standby and special events, national ambulance contract with the federal emergency management agency, and other state agency and health system contracts to coordinate EMS responses. It serves health systems, large regional systems, and smaller independent hospitals, local communities, health systems, payors, public health and local, state, and federal agencies. The company was incorporated in 2015 and is headquartered in Lewisville, Texas.
4400 Hwy 121, Lewisville, TX, United States, 75056
(972) 459-4919
34000
| Name | Title | Year Born |
|---|---|---|
| Mr. Nicola Loporcaro Eng. | CEO & Chairman of the Board | 1965 |
| Mr. Edward Van Horne | COO & President | 1970 |
| Mr. Brian Scott Tierney | Executive VP & CFO | 1972 |
| Mr. Thomas A. A. Cook | Executive VP, General Counsel & Secretary | 1965 |
| Ms. Lisa Jacoba | Executive VP & Chief Human Resources Officer | 1967 |
| Mr. Krister Sorensen | Vice President of Investor Relations | NA |
| Kirsten Gurmendi | Associate Vice President of Public Relations | NA |
| Ms. Tricia Frachetti | Chief Corporate Development Officer | NA |
| Mr. Timothy J. Dorn | Senior VP & Senior Advisor to the CEO | NA |
| Dr. Edward M. Racht M.D. | Chief Medical Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.